DexCom, Inc.

Type: Public
On the web: http://www.dexcom.com
Employees: 620
Employee growth: 19.2%

DexCom wants to bring dexterity and communication to diabetes patients. The company develops and manufactures a glucose monitoring system called SEVEN PLUS that measures and wirelessly transmits blood sugar levels from a sensor on the patient to the company's receiver. Real-time data is processed and displayed so patients can assess blood glucose trends. Patients are also alerted when levels are too high or too low. The company's other product, GlucoClear, is used in hospitals to monitor blood glucose levels in critical care patients. DexCom's products are marketed to physicians, endocrinologists, and diabetes educators in the US and select international markets.

Key numbers for fiscal year ending December, 2011:
Sales: $76.3M
One year growth: 56.8%
Net income: ($44.7)M

Officers:
President, CEO, and Director: Terrance H. (Terry) Gregg
VP and CFO: Jess Roper
CTO: Jorge A. Valdes

Competitors:
Abbott Diabetes Care
Bayer Diabetes Care
Medtronic